Prostate cancer is a significant concern for men, with Prostate Cancer UK highlighting that one in eight men will be affected by the disease in their lifetime, making it the most common cancer among men in the UK. Each year, over 52,000 men are diagnosed with prostate cancer in the country. The recent news of cycling legend Sir Chris Hoy revealing his terminal prostate cancer diagnosis has brought the importance of early detection to the forefront.
Hoy’s diagnosis came about incidentally during a routine scan for shoulder pain, leading to the discovery of a tumour in his shoulder and primary cancer in his prostate that had spread to his bones. Laura Kerby, the chief executive at Prostate Cancer UK, emphasises the need for men to be proactive about their health, as early detection significantly improves treatment outcomes.
Roger Kirby, a former prostate surgeon and professor of urology, points out that prostate cancer claims over 11,000 lives annually in the UK, with a concerning rise in cases among younger men. Identifying the disease in its early stages, while still limited to the prostate, is crucial for better prognosis. Men over 50, particularly those with a family history of the disease or of Afro-Caribbean descent, are at higher risk and should undergo regular monitoring.
Symptoms of early prostate cancer are often absent, underscoring the importance of screening for at-risk individuals. Prostate-specific antigen (PSA) tests can assess PSA levels in the blood, while digital rectal examinations (DRE) allow healthcare professionals to feel for abnormalities in the prostate. Additionally, MRI scans provide detailed insights into the prostate and aid in confirming diagnoses.
Alan White, an emeritus professor of men’s health, stresses the importance of PSA tests as an initial step for men experiencing urinary issues, as they can differentiate between benign prostate conditions and potential cancer. White’s own prostate cancer diagnosis last year underscores the need for proactive health checks and early intervention. MRI scans offer a comprehensive view of the prostate, guiding treatment decisions and improving outcomes.
White encourages men not to shy away from screenings, as timely detection allows for a range of treatment options. By raising awareness and promoting regular screenings, more men can benefit from early diagnosis and effective treatment, ultimately improving survival rates. Regular monitoring and proactive health management play a vital role in combating prostate cancer and safeguarding men’s health.